Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trialSimone Koole, Ruby van Stein, Karolina Sikorska, Desmond Barton, Lewis Perrin, Donal Brennan, Oliver Zivanovic, Berit Jul Mosgaard, Anna Fagotti, Pierre-Emmanuel Colombo, Gabe Sonke, W J van Driel, , on behalf of the OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group, N BakrinSee the full list of authors
23 March 2020
Anti-PD-L1 (atezolizumab) as an immune primer and concurrently with extended-field chemoradiotherapy for node-positive locally advanced cervical cancerJyoti Mayadev, Dmitriy Zamarin, Wei Deng, Heather Lankes, Roisin O'Cearbhaill, Carol A Aghajanian, Russell Schilder
22 December 2019
An exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA study): a randomized controlled pilot trialTabea Maurer, Julia von Grundherr, Stefan Patra, Anna Jaeger, Heiko Becher, Barbara Schmalfeldt, Birgit-Christiane Zyriax, Jenny Chang-Claude
2 December 2019
Oncologic outcome after completing or abandoning (radical) hysterectomy in patients with cervical cancer and intraoperative detection of lymph node positivity; ABRAX (ABandoning RAd hyst in cerviX cancer)Lukas Dostalek, Ingo Runnebaum, Francesco Raspagliesi, Ignace Vergote, Ladislav Dusek, Jiri Jarkovsky, David Cibula
20 November 2019
A randomized phase III trial of platinum chemotherapy plus paclitaxel with bevacizumab and atezolizumab versus platinum chemotherapy plus paclitaxel and bevacizumab in metastatic (stage IVB), persistent, or recurrent carcinoma of the cervix: the BEATcc study (ENGOT-Cx10/GEICO 68-C/JGOG1084/GOG-3030)Juan Francisco Grau, Lorena Farinas-Madrid, Ana Oaknin
23 October 2019
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY)Giovanni Scambia, Camilla Nero, Stefano Uccella, Enrico Vizza, Fabio Ghezzi, Francesco Cosentino, Vito Chiantera, Anna Fagotti
9 October 2019
TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)Alexander Reuss, Andreas du Bois, Philipp Harter, Christina Fotopoulou, Jalid Sehouli, Giovanni Aletti, Frederic Guyon, Stefano Greggi, Berit Jul Mosgaard, Alexander Reinthaller, Felix Hilpert, Carmen Schade-Brittinger, Dennis S Chi, Sven Mahner
15 August 2019
GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM studyDebora Verri, Tina Pasciuto, Elisabeth Epstein, Robert Fruscio, Floriana Mascilini, Francesca Moro, Giovanni Scambia, Lil Valentin, Antonia Carla Testa
26 June 2019
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trialHenrik Falconer, Kolbrun Palsdottir, Karin Stalberg, Pernilla Dahm-Kähler, Ulrika Ottander, Evelyn Serreyn Lundin, Lena Wijk, Rainer Kimmig, Pernille Tine Jensen, Ane Gerda Zahl Eriksson, Johanna Mäenpää, Jan Persson, Sahar Salehi
14 June 2019
FIGO 2018 stage IB2 (2–4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter studyMarie Plante, Nienke van Trommel, Stephanie Lheureux, Amit M Oza, Lisa Wang, Karolina Sikorska, Sarah Elizabeth Ferguson, Kathy Han, Frederic Amant
17 May 2019